OncLive on Air Powered by PER
OncLive On Air® CE
The experts unpack molecular profiling for adult and pediatric low- and high-grade gliomas, including a discussion of targeted therapies for MAPK pathway, IDH, and H3K27M altered disease.
Trending on OncLive
1
FDA Grants Fast Track Designation to Pan-RAS Molecular Glue ERAS-0015 for Metastatic Pancreatic Adenocarcinoma
2
Darlifarnib Plus Cabozantinib Displays Early Signals of Safety and Efficacy in RCC
3
FDA Grants Priority Review to Dostarlimab for dMMR/MSI-H Locally Advanced Rectal Cancer
4
European Commission Approves Sacituzumab Govitecan Plus Pembrolizumab for Frontline PD-L1+ mTNBC
5